We were very happy to participate in Alimetry's Series A capital raise late last year, led by Movac. The company is making substantial progress towards regulatory approvals, setting them up…
Matū Group operates venture capital funds that invest in scalable science and deep tech start-ups in Aotearoa New Zealand. We take a hands-on, active approach to helping early-stage companies have…
Our portfolio company #1 Mekonos has announced an exciting partnership to build designer chromosomes as part of the next generation of cell therapy. These therapies are the key to personalised…
We are excited to announce the most recent addition to the Matū Fund investment portfolio, RosterLab, based on research conducted at the University of Auckland. The newly formed company successfully…
Congratulations to Luke Campbell, co-founder of Vxt and student at the University of Canterbury, for winning the Matū-sponsored Momentum Student Entrepreneur of the Year Award for 2021! The awards were…
MEDIA RELEASE Matū Iramoe’s initial public offering, which went live today on Catalist, offers retail investors a unique opportunity to buy into the rapidly growing deep tech sector. With deep…
We are proud to have participated in Mekonos' latest capital raise as we continue to support their ongoing development, stemming from research originally conducted at the University of Canterbury. Below…